This website uses cookies primarily for visitor analytics. Certain pages will ask you to fill in contact details to receive additional information. On these pages you have the option of having the site log your details for future visits. Indicating you want the site to remember your details will place a cookie on your device. To view our full cookie policy, please click here. You can also view it at any time by going to our Contact Us page.

Close

FSA releases list of permitted CBD products

04 April 2022

The UK has become the first country to regulate the market for safe, orally consumed legal cannabis extracts, following the release of the Food Standards Agency’s public list of cannabinoid (CBD) products permitted for sale to consumers. 

Only those CBD products featured on the list have been given the green light by the FSA to stay on the market, in line with the UK’s Novel Food requirements. Products not included must now be removed from shelves.
CBD products on the FSA list have been undergoing assessment by the agency in a long and rigorous Novel Food process. This was open to any CBD product designed for oral consumption that was on sale in the UK on or before 13 February 2020, with the deadline for applications set at 31 March 2021. Any product launched after 13 February 2020, or which was not the subject of a dossier submitted by the cut-off date, may not now be sold until full authorisation is granted.

The ACI is working in tandem with Trading Standards to enforce the new rules immediately, with any company offering unlisted CBD products for sale facing possible action by its officers. Businesses selling CBD products – including supermarkets, convenience stores, health food shops, pharmacies, online retailers, cafés and restaurants – have been urged to check their current stock against the list to ensure they are compliant. 

ACI has launched a new website – www.UKCBDList.com – to serve as a reference point enabling consumers, retailers, health practitioners and enforcement authorities to verify whether a product is being sold legally.

The FSA list covers products sold in England and Wales. CBD products on sale north of the border are subject to a separate authorisation process managed by Food Standards Scotland. In Northern Ireland, meanwhile, companies must continue to adhere to EU Novel Food rules and procedures as a result of Brexit protocols. Products designed to be inhaled, such as vapes, or applied to the skin, including cosmetics and massage oils, do not fall under the FSA’s remit. These were not assessed and will not appear on the list.


Contact Details and Archive...

Print this page | E-mail this page